NIVOLUMAB

NIVOLUMAB was reported 97932 times

NIVOLUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IMMUNE-MEDIATED UVEITIS 128 0.6995
1 FULMINANT TYPE 1 DIABETES MELLITUS 605 0.5868
2 LEUKODERMA 104 0.5226
3 IMMUNE-MEDIATED HYPOPHYSITIS 224 0.4967
4 IMMUNE-MEDIATED ENCEPHALOPATHY 43 0.4831
5 LYMPHOCYTIC HYPOPHYSITIS 131 0.4746
6 ENDOCRINE TOXICITY 47 0.4608
7 IMMUNE-MEDIATED CYSTITIS 51 0.4435
8 IMMUNE-MEDIATED CHOLANGITIS 158 0.4401
9 IMMUNE-MEDIATED ENDOCRINOPATHY 66 0.4400
10 AUTOIMMUNE COLITIS 273 0.4233
11 IMMUNE-MEDIATED ENTEROCOLITIS 1527 0.4148
12 IMMUNE-MEDIATED LUNG DISEASE 745 0.4082
13 HYPOPHYSITIS 807 0.4009
14 IMMUNE-MEDIATED DERMATITIS 390 0.3869
15 IMMUNE-MEDIATED MYASTHENIA GRAVIS 121 0.3723
16 IMMUNE-MEDIATED HEPATITIS 758 0.3708
17 IMMUNE-MEDIATED THYROIDITIS 183 0.3704
18 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 318 0.3622
19 AUTOIMMUNE NEPHRITIS 79 0.3591
20 IMMUNE-MEDIATED ARTHRITIS 135 0.3543
21 IMMUNE-MEDIATED NEPHRITIS 159 0.3390
22 ADRENALITIS 35 0.3271
23 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 257 0.3225
24 IMMUNE-MEDIATED ENCEPHALITIS 168 0.3176
25 IMMUNE-MEDIATED MYOCARDITIS 508 0.3144
26 IMMUNE-MEDIATED PANCREATITIS 119 0.3123
27 IMMUNE-MEDIATED HEPATIC DISORDER 603 0.3089
28 IMMUNE-MEDIATED HYPERTHYROIDISM 78 0.3071
29 IMMUNE-MEDIATED PNEUMONITIS 71 0.3034
30 IMMUNE-MEDIATED GASTRITIS 58 0.3021
31 IMMUNE-MEDIATED HYPOTHYROIDISM 319 0.2828
32 AUTOIMMUNE MYOCARDITIS 60 0.2740
33 HYPOPITUITARISM 472 0.2711
34 VOGT-KOYANAGI-HARADA DISEASE 59 0.2682
35 SILENT THYROIDITIS 38 0.2639
36 MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME 59 0.2588
37 IMMUNE-MEDIATED RENAL DISORDER 102 0.2464
38 AUTOIMMUNE DERMATITIS 36 0.2384
39 AUTOIMMUNE ARTHRITIS 37 0.2357
40 SECONDARY ADRENOCORTICAL INSUFFICIENCY 347 0.2296
41 RELAPSING FEVER 56 0.1938
42 THYROIDITIS 566 0.1883
43 BLOOD CORTICOTROPHIN DECREASED 91 0.1865
44 TUMOUR PSEUDOPROGRESSION 191 0.1744
45 AUTOIMMUNE HYPOTHYROIDISM 40 0.1681
46 GLUCOCORTICOID DEFICIENCY 66 0.1560
47 EOSINOPHILIC FASCIITIS 53 0.1527
48 HYPOTHALAMO-PITUITARY DISORDER 215 0.1476
49 PRIMARY HYPOTHYROIDISM 31 0.1462
50 AUTOIMMUNE PANCREATITIS 71 0.1403
51 TRI-IODOTHYRONINE FREE DECREASED 33 0.1294
52 SARCOID-LIKE REACTION 32 0.1240
53 IMMUNE-MEDIATED ADVERSE REACTION 183 0.1191
54 ADRENAL INSUFFICIENCY 1442 0.1187
55 TUMOUR ASSOCIATED FEVER 47 0.1149
56 TYPE 1 DIABETES MELLITUS 682 0.1131
57 VITILIGO 263 0.1120
58 THROMBOPHLEBITIS MIGRANS 37 0.1088
59 RADIATION PNEUMONITIS 232 0.1083
60 MYASTHENIC SYNDROME 80 0.1034
61 CENTRAL HYPOTHYROIDISM 33 0.0997
62 PEMPHIGOID 741 0.0981
63 MALIGNANT NEOPLASM PROGRESSION 9963 0.0972
64 CORTISOL DECREASED 111 0.0971
65 INTRACRANIAL TUMOUR HAEMORRHAGE 36 0.0930
66 NON-SMALL CELL LUNG CANCER 441 0.0920
67 MYOCARDITIS 1040 0.0906
68 IMMUNE-MEDIATED MYOSITIS 248 0.0899
69 ENCEPHALITIS AUTOIMMUNE 118 0.0897
70 ENTEROCOLITIS 511 0.0884
71 LICHENOID KERATOSIS 202 0.0884
72 CHOLANGITIS SCLEROSING 179 0.0871
73 ADRENAL DISORDER 165 0.0858
74 MELANOMA RECURRENT 36 0.0855
75 SEROUS RETINAL DETACHMENT 71 0.0847
76 ENDOCRINE DISORDER 108 0.0842
77 TUMOUR PAIN 108 0.0819
78 MYOSITIS 735 0.0818
79 PNEUMONITIS 2219 0.0814
80 NEPHRITIS 266 0.0796
81 METASTATIC MALIGNANT MELANOMA 178 0.0774
82 RADIATION NECROSIS 43 0.0750
83 AUTOIMMUNE HEPATITIS 505 0.0725
84 CYTOMEGALOVIRUS ENTEROCOLITIS 55 0.0714
85 LYMPHANGIOSIS CARCINOMATOSA 73 0.0701
86 HYPERTHYROIDISM 1015 0.0700
87 CHOLANGITIS 425 0.0685
88 HYPOTHYROIDISM 2155 0.0674
89 KERATOACANTHOMA 46 0.0673
90 ASPIRATION PLEURAL CAVITY 51 0.0663
91 SUPERIOR VENA CAVA SYNDROME 40 0.0662
92 ADRENOCORTICAL INSUFFICIENCY ACUTE 129 0.0661
93 CACHEXIA 323 0.0627
94 AUTOIMMUNE MYOSITIS 29 0.0614
95 COLITIS 2300 0.0606
96 MYASTHENIA GRAVIS 485 0.0600
97 LICHEN PLANUS 135 0.0582
98 ENCEPHALITIS 395 0.0570
99 TUMOUR HAEMORRHAGE 155 0.0543
100 AUTOIMMUNE HAEMOLYTIC ANAEMIA 184 0.0536
101 AUTOIMMUNE DISORDER 515 0.0528
102 BILIARY TRACT INFECTION 32 0.0514
103 HEPATOBILIARY DISEASE 32 0.0511
104 PARANEOPLASTIC SYNDROME 34 0.0503
105 THYROID HORMONES INCREASED 51 0.0485
106 AUTOIMMUNE THYROIDITIS 179 0.0473
107 CANCER PAIN 119 0.0465
108 AMYLASE INCREASED 171 0.0463
109 SIALOADENITIS 63 0.0462
110 CYTOKINE STORM 31 0.0453
111 METASTASES TO CENTRAL NERVOUS SYSTEM 581 0.0450
112 HYDROTHORAX 36 0.0434
113 EXPOSURE VIA BODY FLUID 34 0.0433
114 METASTASES TO ADRENALS 39 0.0423
115 TUMOUR NECROSIS 44 0.0416
116 HEPATITIS 1053 0.0411
117 METASTASES TO PLEURA 43 0.0410
118 CYTOKINE RELEASE SYNDROME 822 0.0409
119 MALIGNANT PLEURAL EFFUSION 69 0.0409
120 METASTASES TO SKIN 42 0.0407
121 DERMATOMYOSITIS 103 0.0406
122 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 305 0.0406
123 PULMONARY SEPSIS 59 0.0405
124 METASTATIC RENAL CELL CARCINOMA 74 0.0404
125 MENINGITIS ASEPTIC 181 0.0403
126 RENAL CANCER METASTATIC 31 0.0403
127 SKIN TOXICITY 224 0.0396
128 PULMONARY TOXICITY 273 0.0386
129 CHOLANGITIS ACUTE 29 0.0384
130 RHEUMATIC DISORDER 74 0.0382
131 METASTASES TO MENINGES 87 0.0382
132 IMMUNE THROMBOCYTOPENIA 175 0.0382
133 INTENTIONAL PRODUCT USE ISSUE 3329 0.0380
134 IMMUNE THROMBOCYTOPENIC PURPURA 106 0.0375
135 POLYARTHRITIS 195 0.0370
136 DEMYELINATING POLYNEUROPATHY 38 0.0369
137 THYROID DISORDER 564 0.0366
138 PRERENAL FAILURE 51 0.0362
139 LIPASE INCREASED 277 0.0361
140 THYROTOXIC CRISIS 41 0.0360
141 PANCREATIC ENZYMES INCREASED 52 0.0355
142 POLYMYALGIA RHEUMATICA 112 0.0352
143 INTERSTITIAL LUNG DISEASE 1692 0.0349
144 TROPONIN T INCREASED 44 0.0347
145 POLYMYOSITIS 61 0.0344
146 GUILLAIN-BARRE SYNDROME 162 0.0335
147 HYPERSENSITIVITY PNEUMONITIS 38 0.0334
148 ENTERITIS 213 0.0333
149 HEPATIC FUNCTION ABNORMAL 1235 0.0331
150 PULMONARY SARCOIDOSIS 37 0.0329
151 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 767 0.0329
152 ORGANISING PNEUMONIA 161 0.0325
153 BILIARY OBSTRUCTION 42 0.0324
154 DUODENITIS 99 0.0322
155 INFECTIOUS PLEURAL EFFUSION 49 0.0322
156 PERIPHERAL MOTOR NEUROPATHY 45 0.0321
157 CAPILLARY LEAK SYNDROME 66 0.0319
158 DIABETIC KETOACIDOSIS 748 0.0311
159 BILE DUCT STENOSIS 37 0.0309
160 GASTROINTESTINAL TOXICITY 148 0.0308
161 DERMATITIS PSORIASIFORM 62 0.0303
162 TASTE DISORDER 591 0.0291
163 VITH NERVE PARALYSIS 33 0.0289
164 PANCREATIC FAILURE 51 0.0288
165 LYMPHADENOPATHY MEDIASTINAL 55 0.0287
166 PRESCRIBED UNDERDOSE 570 0.0285
167 RADIATION SKIN INJURY 33 0.0284
168 THYROID FUNCTION TEST ABNORMAL 118 0.0284
169 HYPERCALCAEMIA 350 0.0283
170 UVEITIS 383 0.0282
171 TROPONIN I INCREASED 47 0.0282
172 PACKED RED BLOOD CELL TRANSFUSION 37 0.0279
173 BLOOD THYROID STIMULATING HORMONE DECREASED 127 0.0279
174 BLOOD THYROID STIMULATING HORMONE INCREASED 257 0.0279
175 ENTEROCOLITIS HAEMORRHAGIC 41 0.0277
176 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 31 0.0276
177 HYPOALBUMINAEMIA 215 0.0276
178 TUBULOINTERSTITIAL NEPHRITIS 518 0.0276
179 STEROID DIABETES 41 0.0273
180 CARDIAC TAMPONADE 129 0.0271
181 MYELITIS 42 0.0271
182 METASTASES TO LUNG 313 0.0271
183 ERYTHEMA MULTIFORME 247 0.0265
184 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 45 0.0253
185 PNEUMONIA BACTERIAL 226 0.0246
186 PHYSICAL DECONDITIONING 63 0.0245
187 HEPATITIS FULMINANT 72 0.0242
188 LIVER DISORDER 1075 0.0242
189 HYPERTRANSAMINASAEMIA 168 0.0241
190 IRIDOCYCLITIS 76 0.0240
191 HEPATIC CYTOLYSIS 304 0.0238
192 METASTASES TO PERITONEUM 60 0.0237
193 PNEUMOCYSTIS JIROVECII PNEUMONIA 238 0.0237
194 APLASIA PURE RED CELL 81 0.0235
195 SMALL INTESTINAL PERFORATION 44 0.0234
196 LUNG ABSCESS 49 0.0233
197 NEPHROTIC SYNDROME 160 0.0233
198 GASTROINTESTINAL PERFORATION 97 0.0233
199 DISSEMINATED INTRAVASCULAR COAGULATION 328 0.0233
200 RASH MACULO-PAPULAR 511 0.0229
201 RENAL TUBULAR ACIDOSIS 50 0.0229
202 METASTASES TO SPINE 77 0.0229
203 RENAL CELL CARCINOMA 111 0.0227
204 CHRONIC GASTRITIS 51 0.0226
205 BLOOD THYROID STIMULATING HORMONE ABNORMAL 41 0.0222
206 EMBOLISM 182 0.0219
207 IGA NEPHROPATHY 36 0.0217
208 LUNG OPACITY 57 0.0216
209 PERIPHERAL SENSORY NEUROPATHY 126 0.0215
210 FACIAL PARALYSIS 182 0.0213
211 JAUNDICE CHOLESTATIC 75 0.0212
212 CELL DEATH 42 0.0212
213 PRESCRIBED OVERDOSE 406 0.0210
214 MYASTHENIA GRAVIS CRISIS 31 0.0209
215 TROPONIN INCREASED 159 0.0209
216 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 30 0.0209
217 NON-CARDIAC CHEST PAIN 66 0.0208
218 MENINGITIS 139 0.0208
219 PERICARDIAL EFFUSION 481 0.0208
220 METASTASES TO LYMPH NODES 137 0.0203
221 PARAPARESIS 36 0.0202
222 LARGE INTESTINE PERFORATION 138 0.0199
223 CHOLESTASIS 376 0.0196
224 ATRIOVENTRICULAR BLOCK COMPLETE 131 0.0196
225 TOXIC EPIDERMAL NECROLYSIS 297 0.0195
226 GLOMERULONEPHRITIS 47 0.0192
227 ASPARTATE AMINOTRANSFERASE ABNORMAL 29 0.0190
228 MIXED LIVER INJURY 57 0.0189
229 PLEURAL EFFUSION 1128 0.0185
230 POLYNEUROPATHY 219 0.0183
231 HYPERKERATOSIS 100 0.0181
232 OESOPHAGEAL STENOSIS 51 0.0179
233 VOCAL CORD PARALYSIS 32 0.0178
234 COLITIS MICROSCOPIC 84 0.0177
235 APPETITE DISORDER 117 0.0176
236 EMPYEMA 35 0.0176
237 PROCTITIS 49 0.0175
238 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 66 0.0173
239 HEPATOTOXICITY 383 0.0172
240 ASCITES 500 0.0170
241 LIVER ABSCESS 55 0.0169
242 PNEUMOTHORAX 268 0.0169
243 METASTASES TO BONE 275 0.0167
244 OESOPHAGITIS 183 0.0167
245 TUMOUR LYSIS SYNDROME 147 0.0167
246 CHOLECYSTITIS 199 0.0167
247 DERMATITIS EXFOLIATIVE GENERALISED 58 0.0167
248 OSTEOLYSIS 34 0.0166
249 SUDDEN DEATH 176 0.0166
250 MUCOSAL INFLAMMATION 435 0.0166
251 ASPARTATE AMINOTRANSFERASE INCREASED 875 0.0165
252 PATHOLOGICAL FRACTURE 83 0.0163
253 BILE DUCT OBSTRUCTION 31 0.0163
254 RADICULOPATHY 43 0.0163
255 DRUG ERUPTION 289 0.0163
256 PERFORMANCE STATUS DECREASED 76 0.0163
257 PNEUMONIA ASPIRATION 406 0.0162
258 SPINAL CORD COMPRESSION 63 0.0162
259 BRAIN OEDEMA 204 0.0161
260 DERMATITIS ACNEIFORM 98 0.0161
261 DERMATITIS BULLOUS 116 0.0160
262 FAILURE TO THRIVE 83 0.0160
263 HYPONATRAEMIA 899 0.0159
264 HYPOPROTEINAEMIA 30 0.0158
265 ESCHERICHIA URINARY TRACT INFECTION 67 0.0157
266 EYELID PTOSIS 157 0.0154
267 GASTRIC PERFORATION 42 0.0154
268 INTESTINAL PERFORATION 173 0.0154
269 HEPATITIS ACUTE 99 0.0152
270 STEVENS-JOHNSON SYNDROME 337 0.0151
271 HAEMOLYTIC ANAEMIA 135 0.0151
272 NEOPLASM 173 0.0150
273 STOMATITIS 906 0.0149
274 METASTASES TO LIVER 262 0.0149
275 SMALL INTESTINAL HAEMORRHAGE 30 0.0149
276 HEPATOCELLULAR INJURY 211 0.0149
277 TRANSAMINASES INCREASED 325 0.0146
278 METASTASIS 104 0.0146
279 HYPERGLYCAEMIA 528 0.0145
280 ILEUS 180 0.0145
281 KIDNEY TRANSPLANT REJECTION 69 0.0144
282 CHOLESTATIC LIVER INJURY 32 0.0144
283 GLOSSITIS 51 0.0144
284 CYTOMEGALOVIRUS COLITIS 33 0.0143
285 GENERAL PHYSICAL CONDITION ABNORMAL 97 0.0143
286 PULMONARY TUBERCULOSIS 61 0.0143
287 TOXIC SKIN ERUPTION 142 0.0141
288 MULTIPLE ORGAN DYSFUNCTION SYNDROME 399 0.0141
289 RASH MORBILLIFORM 39 0.0141
290 DEATH 12098 0.0140
291 ALANINE AMINOTRANSFERASE INCREASED 862 0.0140
292 GENERAL PHYSICAL HEALTH DETERIORATION 1616 0.0140
293 HEPATIC FAILURE 420 0.0139
294 LUNG INFECTION 216 0.0139
295 TRANSFUSION 145 0.0138
296 KERATITIS 42 0.0138
297 OESOPHAGEAL CANDIDIASIS 55 0.0138
298 DERMATITIS 288 0.0137
299 HAEMOPTYSIS 382 0.0137
300 HEPATIC LESION 59 0.0136
301 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 140 0.0136
302 LUNG DISORDER 664 0.0135
303 PAPILLOEDEMA 61 0.0135
304 ESCHERICHIA SEPSIS 39 0.0134
305 INCORRECT PRODUCT STORAGE 176 0.0134
306 ADVERSE EVENT 1234 0.0134
307 ACUTE RESPIRATORY FAILURE 256 0.0133
308 GAMMA-GLUTAMYLTRANSFERASE INCREASED 294 0.0133
309 SARCOIDOSIS 63 0.0132
310 SKIN DISORDER 442 0.0132
311 ATELECTASIS 127 0.0131
312 BLOOD ALKALINE PHOSPHATASE INCREASED 325 0.0131
313 MYOPATHY 113 0.0131
314 URINARY TRACT OBSTRUCTION 31 0.0131
315 LIVER FUNCTION TEST INCREASED 280 0.0130
316 HEPATITIS CHOLESTATIC 78 0.0129
317 EXTRAVASATION 53 0.0129
318 DIABETES INSIPIDUS 31 0.0129
319 MALNUTRITION 143 0.0128
320 DECREASED APPETITE 2949 0.0127
321 EOSINOPHILIC PNEUMONIA 40 0.0127
322 ENCEPHALOPATHY 310 0.0126
323 ACUTE KIDNEY INJURY 1922 0.0125
324 HYPOKALAEMIA 577 0.0125
325 BLOOD LACTATE DEHYDROGENASE INCREASED 195 0.0123
326 RESPIRATORY FAILURE 892 0.0122
327 DRUG-INDUCED LIVER INJURY 383 0.0122
328 FEBRILE NEUTROPENIA 808 0.0122
329 PLEURISY 72 0.0121
330 ILEUS PARALYTIC 54 0.0121
331 APLASTIC ANAEMIA 63 0.0121
332 ORAL FUNGAL INFECTION 33 0.0120
333 THERAPY PARTIAL RESPONDER 188 0.0120
334 ULCERATIVE KERATITIS 33 0.0120
335 ERYSIPELAS 60 0.0119
336 BRONCHIOLITIS 42 0.0119
337 GRANULOMA 41 0.0118
338 PARAPLEGIA 34 0.0118
339 HYDRONEPHROSIS 88 0.0117
340 CEREBRAL INFARCTION 284 0.0116
341 NEPHROPATHY TOXIC 130 0.0116
342 PERIPHERAL ISCHAEMIA 47 0.0115
343 CARDIOMYOPATHY 170 0.0115
344 DUODENAL ULCER 81 0.0115
345 VENOUS THROMBOSIS 45 0.0115
346 SEPSIS 1273 0.0114
347 EOSINOPHILIA 200 0.0114
348 EOSINOPHIL COUNT INCREASED 95 0.0114
349 STRESS CARDIOMYOPATHY 66 0.0113
350 ACUTE CORONARY SYNDROME 94 0.0113
351 CHOLECYSTITIS ACUTE 64 0.0113
352 DEAFNESS NEUROSENSORY 37 0.0112
353 SEPTIC SHOCK 484 0.0111
354 TONGUE DISCOMFORT 47 0.0111
355 HYPERTHERMIA 84 0.0110
356 PYREXIA 3792 0.0109
357 PROTEINURIA 207 0.0109
358 HISTIOCYTOSIS HAEMATOPHAGIC 32 0.0108
359 BLOOD CREATINE PHOSPHOKINASE INCREASED 310 0.0108
360 AGRANULOCYTOSIS 200 0.0107
361 HYPOXIA 378 0.0107
362 ATYPICAL PNEUMONIA 32 0.0107
363 HYPOPHOSPHATAEMIA 79 0.0107
364 NEOPLASM RECURRENCE 36 0.0106
365 THROMBOCYTOPENIA 1185 0.0106
366 INFUSION RELATED REACTION 700 0.0106
367 C-REACTIVE PROTEIN INCREASED 384 0.0105
368 PNEUMATOSIS INTESTINALIS 30 0.0105
369 CARDIAC FAILURE ACUTE 70 0.0105
370 OPTIC NEURITIS 95 0.0104
371 GRAFT VERSUS HOST DISEASE 75 0.0104
372 CUTANEOUS VASCULITIS 38 0.0104
373 NEUTROPHIL COUNT DECREASED 424 0.0104
374 ELECTROLYTE IMBALANCE 119 0.0102
375 MALIGNANT MELANOMA 137 0.0102
376 PORTAL VEIN THROMBOSIS 33 0.0102
377 CARDIAC DYSFUNCTION 38 0.0102
378 ALTERED STATE OF CONSCIOUSNESS 221 0.0102
379 PERICARDITIS 171 0.0102
380 BACTERAEMIA 120 0.0101
381 HEPATITIS B REACTIVATION 32 0.0101
382 BLOOD BILIRUBIN INCREASED 272 0.0101
383 TONGUE ULCERATION 34 0.0101
384 BILE DUCT STONE 32 0.0101
385 SHOCK HAEMORRHAGIC 81 0.0099
386 CLOSTRIDIUM DIFFICILE COLITIS 105 0.0099
387 PULMONARY HAEMORRHAGE 77 0.0098
388 ATRIOVENTRICULAR BLOCK 76 0.0098
389 NEUTROPENIC SEPSIS 70 0.0098
390 HYPERURICAEMIA 40 0.0097
391 VASCULAR DEVICE INFECTION 44 0.0097
392 BRONCHOPULMONARY ASPERGILLOSIS 75 0.0097
393 KETOACIDOSIS 72 0.0096
394 ANAEMIA 1817 0.0095
395 LYMPHOCYTE COUNT DECREASED 168 0.0095
396 GASTRITIS 250 0.0095
397 LYMPHOCYTE COUNT INCREASED 31 0.0095
398 LYMPHADENOPATHY 331 0.0093
399 NECROSIS 52 0.0093
400 HEPATIC ENCEPHALOPATHY 87 0.0093
401 SKIN EROSION 30 0.0093
402 PULMONARY ALVEOLAR HAEMORRHAGE 52 0.0093
403 NEOPLASM PROGRESSION 322 0.0092
404 OESOPHAGEAL ULCER 35 0.0091
405 THROMBOTIC THROMBOCYTOPENIC PURPURA 32 0.0091
406 SCLERODERMA 33 0.0091
407 ASPERGILLUS INFECTION 59 0.0090
408 ORAL CANDIDIASIS 117 0.0089
409 BONE LESION 32 0.0089
410 CARDIAC FAILURE 708 0.0088
411 BRAIN NEOPLASM 81 0.0088
412 SENSITIVE SKIN 65 0.0088
413 GENERALISED OEDEMA 109 0.0088
414 FEMORAL NECK FRACTURE 45 0.0088
415 PANCREATIC DISORDER 43 0.0087
416 PULMONARY EMBOLISM 828 0.0087
417 HUMERUS FRACTURE 42 0.0087
418 CHEILITIS 47 0.0087
419 PANCREATITIS 459 0.0087
420 NEUROTOXICITY 151 0.0086
421 PYELONEPHRITIS 74 0.0085
422 ORAL PAIN 191 0.0085
423 AZOTAEMIA 34 0.0085
424 BLOOD CREATININE INCREASED 555 0.0085
425 HYPOMAGNESAEMIA 118 0.0085
426 DIABETES MELLITUS 643 0.0084
427 HYPERBILIRUBINAEMIA 87 0.0084
428 SMALL INTESTINAL OBSTRUCTION 103 0.0084
429 HYPOCALCAEMIA 158 0.0083
430 SKIN ULCER 215 0.0083
431 ATRIAL FLUTTER 66 0.0083
432 DIARRHOEA 5336 0.0083
433 UROSEPSIS 76 0.0082
434 LOCALISED OEDEMA 38 0.0082
435 ACUTE MYELOID LEUKAEMIA 127 0.0081
436 HAIR COLOUR CHANGES 101 0.0081
437 METASTATIC NEOPLASM 35 0.0081
438 DEVICE RELATED INFECTION 124 0.0080
439 ACUTE RESPIRATORY DISTRESS SYNDROME 142 0.0080
440 JAUNDICE 216 0.0080
441 RESPIRATORY DISTRESS 220 0.0080
442 CEREBRAL ISCHAEMIA 41 0.0080
443 HYPERKALAEMIA 278 0.0079
444 FLANK PAIN 74 0.0079
445 PNEUMONIA FUNGAL 31 0.0079
446 DIPLOPIA 203 0.0078
447 PNEUMONIA 2499 0.0077
448 RENAL TUBULAR NECROSIS 75 0.0076
449 HEPATIC ENZYME INCREASED 521 0.0076
450 ENDOCARDITIS 39 0.0076
451 DEHYDRATION 1011 0.0076
452 RENAL DISORDER 353 0.0076
453 CEREBRAL DISORDER 56 0.0076
454 CYTOPENIA 92 0.0075
455 NEUROPATHY PERIPHERAL 714 0.0075
456 LUNG NEOPLASM 32 0.0075
457 HOSPICE CARE 74 0.0075
458 LEFT VENTRICULAR DYSFUNCTION 50 0.0075
459 ACUTE HEPATIC FAILURE 102 0.0075
460 CARDIOGENIC SHOCK 107 0.0074
461 DELIRIUM 258 0.0074
462 PANCYTOPENIA 415 0.0074
463 OFF LABEL USE 6485 0.0074
464 CARDIOTOXICITY 66 0.0074
465 ARTHRITIS 582 0.0074
466 CHRONIC LYMPHOCYTIC LEUKAEMIA 35 0.0074
467 HAEMATURIA 251 0.0073
468 BLOOD ALBUMIN DECREASED 58 0.0073
469 VASCULITIS 85 0.0073
470 VENOOCCLUSIVE LIVER DISEASE 36 0.0073
471 GASTROINTESTINAL MOTILITY DISORDER 39 0.0073
472 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 186 0.0072
473 CONJUNCTIVITIS 134 0.0072
474 LEUKOPENIA 361 0.0072
475 RASH 3143 0.0072
476 SUPRAVENTRICULAR TACHYCARDIA 69 0.0072
477 LUMBAR VERTEBRAL FRACTURE 33 0.0072
478 ACIDOSIS 55 0.0072
479 LUNG INFILTRATION 63 0.0071
480 DECUBITUS ULCER 58 0.0071
481 PULMONARY MASS 106 0.0071
482 FEBRILE BONE MARROW APLASIA 30 0.0071
483 PLATELET COUNT DECREASED 750 0.0070
484 ASPIRATION 77 0.0070
485 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 67 0.0070
486 ABDOMINAL ABSCESS 31 0.0070
487 CORONAVIRUS INFECTION 46 0.0069
488 RENAL FUNCTION TEST ABNORMAL 32 0.0069
489 SKIN REACTION 97 0.0069
490 NEUTROPENIA 934 0.0069
491 DIVERTICULUM INTESTINAL 30 0.0069
492 HYDROCEPHALUS 37 0.0068
493 GASTROENTERITIS 99 0.0068
494 WEIGHT DECREASED 1887 0.0068
495 BLISTER 378 0.0067
496 HEMIPARESIS 114 0.0067
497 ISCHAEMIC STROKE 120 0.0067
498 STAPHYLOCOCCAL SEPSIS 33 0.0067
499 HYPOVOLAEMIC SHOCK 32 0.0067
500 DYSPHONIA 390 0.0067
501 NEUROLOGICAL SYMPTOM 38 0.0066
502 ATRIAL FIBRILLATION 647 0.0066
503 BLOOD SODIUM DECREASED 125 0.0066
504 HYPERNATRAEMIA 33 0.0066
505 SINUS TACHYCARDIA 94 0.0066
506 RENAL IMPAIRMENT 555 0.0066
507 RASH PRURITIC 357 0.0066
508 HICCUPS 54 0.0066
509 HYPOPHAGIA 168 0.0066
510 PRODUCT PREPARATION ISSUE 43 0.0065
511 APPENDICITIS 61 0.0065
512 KLEBSIELLA INFECTION 33 0.0065
513 LYMPHOEDEMA 45 0.0065
514 INTESTINAL OBSTRUCTION 244 0.0065
515 INTRACRANIAL PRESSURE INCREASED 36 0.0065
516 CONSTIPATION 1403 0.0064
517 PROTEIN URINE PRESENT 32 0.0064
518 MELAENA 141 0.0064
519 DRY MOUTH 519 0.0064
520 COMPRESSION FRACTURE 34 0.0063
521 DYSPHAGIA 602 0.0063
522 HYPOVOLAEMIA 37 0.0063
523 HAEMATOTOXICITY 60 0.0063
524 IMMUNE SYSTEM DISORDER 83 0.0063
525 RHABDOMYOLYSIS 259 0.0062
526 ESCHERICHIA INFECTION 51 0.0062
527 BLOOD DISORDER 49 0.0061
528 PARALYSIS 87 0.0061
529 HERPES VIRUS INFECTION 35 0.0061
530 SERUM FERRITIN INCREASED 32 0.0061
531 SKIN INFECTION 68 0.0061
532 PERITONITIS 125 0.0060
533 SECOND PRIMARY MALIGNANCY 50 0.0060
534 OEDEMA 326 0.0060
535 MYELOSUPPRESSION 215 0.0060
536 GASTRIC ULCER HAEMORRHAGE 33 0.0059
537 LOWER GASTROINTESTINAL HAEMORRHAGE 44 0.0059
538 MUSCULAR WEAKNESS 675 0.0059
539 HEPATOCELLULAR CARCINOMA 45 0.0059
540 CHILLS 693 0.0059
541 RENAL FAILURE 784 0.0059
542 ACUTE MYOCARDIAL INFARCTION 174 0.0059
543 CYTOMEGALOVIRUS INFECTION 98 0.0059
544 CENTRAL NERVOUS SYSTEM LESION 81 0.0059
545 DISEASE PROGRESSION 692 0.0058
546 SQUAMOUS CELL CARCINOMA 55 0.0058
547 PAPULE 41 0.0058
548 BENIGN PROSTATIC HYPERPLASIA 30 0.0058
549 LEUKOCYTOSIS 105 0.0058
550 GASTRIC ULCER 110 0.0058
551 CEREBRAL HAEMORRHAGE 207 0.0058
552 PURPURA 51 0.0058
553 SKIN LESION 158 0.0058
554 ATAXIA 68 0.0057
555 ACUTE PULMONARY OEDEMA 32 0.0057
556 ASTHENIA 2138 0.0057
557 COVID-19 PNEUMONIA 67 0.0057
558 AGEUSIA 141 0.0056
559 PANCREATITIS ACUTE 127 0.0056
560 SPINAL PAIN 66 0.0056
561 INTESTINAL ISCHAEMIA 31 0.0056
562 MYELODYSPLASTIC SYNDROME 81 0.0056
563 SPINAL COMPRESSION FRACTURE 46 0.0056
564 DIARRHOEA HAEMORRHAGIC 52 0.0056
565 RETINAL DETACHMENT 51 0.0055
566 THROMBOTIC MICROANGIOPATHY 54 0.0055
567 PIGMENTATION DISORDER 34 0.0055
568 FATIGUE 4264 0.0055
569 PRODUCT USE IN UNAPPROVED INDICATION 1356 0.0055
570 SQUAMOUS CELL CARCINOMA OF SKIN 33 0.0055
571 EJECTION FRACTION DECREASED 84 0.0054
572 PULMONARY OEDEMA 242 0.0054
573 SHOCK 124 0.0054
574 DEEP VEIN THROMBOSIS 350 0.0054
575 LIVER INJURY 132 0.0054
576 UPPER GASTROINTESTINAL HAEMORRHAGE 90 0.0053
577 POSTOPERATIVE WOUND INFECTION 36 0.0053
578 HAEMOLYSIS 41 0.0053
579 EPILEPSY 161 0.0053
580 NASAL DRYNESS 33 0.0053
581 DYSPNOEA EXERTIONAL 196 0.0052
582 PRODUCT STORAGE ERROR 455 0.0052
583 URINARY RETENTION 173 0.0052
584 CHROMATURIA 117 0.0052
585 ANGIOPATHY 29 0.0052
586 INFLAMMATION 264 0.0051
587 CIRCULATORY COLLAPSE 87 0.0051
588 INGUINAL HERNIA 31 0.0051
589 LYMPHOPENIA 72 0.0051
590 FAECES SOFT 37 0.0051
591 FRACTURE 96 0.0051
592 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 30 0.0051
593 PULMONARY FIBROSIS 97 0.0051
594 BLOOD TEST ABNORMAL 71 0.0050
595 APHTHOUS ULCER 39 0.0050
596 HAEMORRHAGE INTRACRANIAL 75 0.0050
597 TRANSPLANT REJECTION 40 0.0050
598 WEIGHT FLUCTUATION 52 0.0050
599 OEDEMA PERIPHERAL 605 0.0050
600 CANDIDA INFECTION 83 0.0049
601 MUSCULOSKELETAL CHEST PAIN 76 0.0049
602 DIVERTICULITIS 136 0.0049
603 GINGIVAL PAIN 39 0.0049
604 COLITIS ISCHAEMIC 33 0.0049
605 BACK PAIN 1130 0.0049
606 MOUTH ULCERATION 102 0.0048
607 WOUND INFECTION 53 0.0048
608 INFUSION SITE EXTRAVASATION 30 0.0048
609 APHASIA 145 0.0048
610 DYSPNOEA 2709 0.0048
611 PSEUDOMONAS INFECTION 41 0.0048
612 REBOUND EFFECT 54 0.0048
613 IRON DEFICIENCY ANAEMIA 44 0.0048
614 HYPOTENSION 955 0.0048
615 FEEDING DISORDER 96 0.0047
616 PRURITUS 1818 0.0047
617 BLOOD PRESSURE INCREASED 717 0.0047
618 SUBDURAL HAEMATOMA 67 0.0047
619 BONE MARROW FAILURE 95 0.0047
620 MASS 65 0.0046
621 ANURIA 40 0.0046
622 CELLULITIS 234 0.0046
623 TOOTH DISORDER 103 0.0046
624 MUSCULOSKELETAL PAIN 238 0.0045
625 THIRST 81 0.0045
626 RASH PUSTULAR 33 0.0045
627 POLYURIA 37 0.0045
628 TENDERNESS 47 0.0045
629 EATING DISORDER 96 0.0045
630 MENTAL STATUS CHANGES 125 0.0045
631 CLOSTRIDIUM DIFFICILE INFECTION 98 0.0045
632 VOMITING 2108 0.0045
633 NERVOUS SYSTEM DISORDER 139 0.0044
634 NODULE 58 0.0044
635 GASTRIC HAEMORRHAGE 51 0.0044
636 SUBARACHNOID HAEMORRHAGE 45 0.0044
637 BLOOD MAGNESIUM DECREASED 38 0.0044
638 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 229 0.0044
639 VENTRICULAR TACHYCARDIA 72 0.0044
640 HAEMATEMESIS 110 0.0043
641 BLOOD CALCIUM INCREASED 38 0.0043
642 PRODUCT PREPARATION ERROR 89 0.0043
643 BODY TEMPERATURE INCREASED 88 0.0043
644 BOWEL MOVEMENT IRREGULARITY 33 0.0043
645 PHOTOSENSITIVITY REACTION 71 0.0043
646 FACE OEDEMA 72 0.0043
647 IMPAIRED HEALING 140 0.0043
648 RESPIRATORY TRACT INFECTION 111 0.0043
649 HYPERTENSION 901 0.0042
650 PRODUCTIVE COUGH 203 0.0042
651 MYALGIA 722 0.0042
652 OSTEONECROSIS OF JAW 105 0.0042
653 LIVER FUNCTION TEST ABNORMAL 123 0.0042
654 ORAL DISORDER 31 0.0042
655 ANAPHYLACTIC SHOCK 109 0.0042
656 DERMATITIS ALLERGIC 53 0.0042
657 CARDIO-RESPIRATORY ARREST 175 0.0042
658 OXYGEN SATURATION DECREASED 233 0.0041
659 COUGH 1156 0.0041
660 URINE OUTPUT DECREASED 36 0.0041
661 SEIZURE 475 0.0041
662 ARRHYTHMIA 194 0.0041
663 GASTROINTESTINAL INFLAMMATION 32 0.0041
664 NAUSEA 3233 0.0041
665 DYSGEUSIA 302 0.0041
666 EMPHYSEMA 41 0.0041
667 HYPERTENSIVE CRISIS 45 0.0040
668 DIFFUSE LARGE B-CELL LYMPHOMA 31 0.0040
669 SPINAL DISORDER 38 0.0040
670 ABDOMINAL PAIN 932 0.0040
671 URINARY TRACT INFECTION 682 0.0040
672 DEPRESSED LEVEL OF CONSCIOUSNESS 158 0.0040
673 GROIN PAIN 35 0.0040
674 METABOLIC ACIDOSIS 124 0.0039
675 RESPIRATORY DISORDER 116 0.0039
676 POST PROCEDURAL COMPLICATION 74 0.0038
677 SPLENOMEGALY 45 0.0038
678 PULMONARY HYPERTENSION 80 0.0038
679 INFECTION 554 0.0038
680 BLOOD CALCIUM DECREASED 43 0.0038
681 CONFUSIONAL STATE 617 0.0038
682 NEUTROPHIL COUNT INCREASED 39 0.0038
683 TYPE 2 DIABETES MELLITUS 128 0.0038
684 HERPES ZOSTER 218 0.0038
685 STAPHYLOCOCCAL INFECTION 125 0.0038
686 ANAPHYLACTIC REACTION 209 0.0038
687 SPINAL OSTEOARTHRITIS 33 0.0038
688 RASH PAPULAR 84 0.0037
689 GASTROINTESTINAL DISORDER 335 0.0037
690 TACHYCARDIA 329 0.0037
691 NEURALGIA 90 0.0037
692 TEMPERATURE INTOLERANCE 38 0.0037
693 ARTHRALGIA 1524 0.0037
694 NEPHROPATHY 34 0.0036
695 BONE PAIN 213 0.0036
696 DRY SKIN 485 0.0036
697 PHARYNGITIS 45 0.0036
698 BLOOD IRON DECREASED 43 0.0036
699 MALAISE 1589 0.0036
700 RASH MACULAR 126 0.0036
701 NIGHT SWEATS 116 0.0036
702 HAEMORRHOIDS 70 0.0036
703 ULCER 57 0.0036
704 COLITIS ULCERATIVE 160 0.0036
705 NECK PAIN 200 0.0036
706 HYPOGLYCAEMIA 173 0.0036
707 HEPATIC CIRRHOSIS 67 0.0036
708 WHITE BLOOD CELL COUNT DECREASED 386 0.0036
709 HAEMATOCHEZIA 196 0.0035
710 TACHYPNOEA 48 0.0035
711 WHITE BLOOD CELL COUNT INCREASED 135 0.0035
712 VENTRICULAR FIBRILLATION 39 0.0035
713 BRONCHOSPASM 50 0.0035
714 CARDIAC ARREST 288 0.0035
715 SYNCOPE 348 0.0035
716 INFLAMMATORY BOWEL DISEASE 34 0.0035
717 MUSCLE ATROPHY 44 0.0035
718 BLOOD PRESSURE DECREASED 230 0.0035
719 RHEUMATOID ARTHRITIS 393 0.0035
720 GASTROINTESTINAL HAEMORRHAGE 289 0.0035
721 ORAL DISCOMFORT 48 0.0035
722 MYOCARDIAL ISCHAEMIA 39 0.0034
723 THERAPY NON-RESPONDER 154 0.0034
724 FEELING COLD 95 0.0034
725 BLOOD UREA INCREASED 57 0.0034
726 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 186 0.0034
727 HOSPITALISATION 519 0.0034
728 GINGIVAL BLEEDING 46 0.0034
729 DEAFNESS 88 0.0034
730 BLOOD POTASSIUM DECREASED 101 0.0034
731 GAIT INABILITY 112 0.0033
732 MOTOR DYSFUNCTION 34 0.0033
733 GLOSSODYNIA 74 0.0033
734 PRODUCT USE ISSUE 619 0.0033
735 LABORATORY TEST ABNORMAL 97 0.0033
736 COGNITIVE DISORDER 153 0.0033
737 OSTEOMYELITIS 59 0.0033
738 HEPATOMEGALY 32 0.0033
739 BLOOD PRESSURE SYSTOLIC INCREASED 63 0.0032
740 ANGINA PECTORIS 92 0.0032
741 RIB FRACTURE 66 0.0032
742 DYSARTHRIA 120 0.0032
743 THROMBOSIS 256 0.0032
744 CHEST PAIN 581 0.0031
745 PEMPHIGUS 39 0.0031
746 CYSTITIS 99 0.0031
747 SINUS BRADYCARDIA 30 0.0031
748 INCREASED APPETITE 59 0.0031
749 BRONCHITIS 227 0.0031
750 BACTERIAL INFECTION 57 0.0031
751 PULMONARY THROMBOSIS 33 0.0030
752 FISTULA 34 0.0030
753 SKIN EXFOLIATION 255 0.0030
754 DRY EYE 150 0.0030
755 ERYTHEMA 614 0.0030
756 PRODUCT PRESCRIBING ISSUE 65 0.0030
757 RECTAL HAEMORRHAGE 128 0.0030
758 HYPERSOMNIA 85 0.0030
759 GOUT 53 0.0030
760 DYSURIA 108 0.0029
761 EPISTAXIS 218 0.0029
762 ECZEMA 152 0.0029
763 PULMONARY CONGESTION 38 0.0029
764 HEPATIC STEATOSIS 53 0.0028
765 INCONTINENCE 30 0.0028
766 BLOOD POTASSIUM INCREASED 46 0.0028
767 DISORIENTATION 112 0.0028
768 HAEMOGLOBIN DECREASED 290 0.0028
769 COVID-19 495 0.0028
770 FAECES DISCOLOURED 61 0.0028
771 VERTIGO 171 0.0028
772 TRANSIENT ISCHAEMIC ATTACK 94 0.0028
773 DECREASED ACTIVITY 30 0.0028
774 GLOMERULAR FILTRATION RATE DECREASED 34 0.0028
775 MOVEMENT DISORDER 88 0.0027
776 SECRETION DISCHARGE 34 0.0027
777 PRESYNCOPE 66 0.0027
778 ORTHOSTATIC HYPOTENSION 47 0.0027
779 POST PROCEDURAL HAEMORRHAGE 31 0.0027
780 RESPIRATORY TRACT CONGESTION 42 0.0026
781 BASAL CELL CARCINOMA 41 0.0026
782 CATARACT 156 0.0026
783 POLLAKIURIA 109 0.0026
784 GENERALISED TONIC-CLONIC SEIZURE 43 0.0026
785 DIABETES MELLITUS INADEQUATE CONTROL 46 0.0026
786 TOOTHACHE 47 0.0026
787 DISCOMFORT 158 0.0026
788 APHONIA 36 0.0026
789 MUSCULOSKELETAL DISORDER 49 0.0026
790 CYANOSIS 40 0.0025
791 PERIPHERAL SWELLING 391 0.0025
792 RASH ERYTHEMATOUS 121 0.0025
793 CHOLELITHIASIS 83 0.0025
794 ABDOMINAL DISTENSION 264 0.0025
795 ABDOMINAL PAIN UPPER 520 0.0025
796 HYPOAESTHESIA ORAL 38 0.0025
797 HAEMATOMA 65 0.0025
798 BLOOD PRESSURE FLUCTUATION 60 0.0025
799 SPINAL FRACTURE 50 0.0025
800 INFLUENZA LIKE ILLNESS 205 0.0025
801 GAIT DISTURBANCE 476 0.0025
802 SOMNOLENCE 497 0.0025
803 SKIN DISCOLOURATION 113 0.0025
804 HIP FRACTURE 79 0.0025
805 DRUG RESISTANCE 63 0.0025
806 BEDRIDDEN 32 0.0024
807 FALL 807 0.0024
808 FEMUR FRACTURE 75 0.0024
809 OROPHARYNGEAL PAIN 224 0.0024
810 IMMUNODEFICIENCY 36 0.0024
811 ORAL HERPES 47 0.0024
812 EYE DISORDER 79 0.0024
813 COAGULOPATHY 40 0.0024
814 DYSPEPSIA 236 0.0024
815 DEMENTIA 67 0.0024
816 SCIATICA 38 0.0024
817 ABSCESS 38 0.0024
818 LIMB DISCOMFORT 73 0.0024
819 GALLBLADDER DISORDER 42 0.0024
820 LOWER RESPIRATORY TRACT INFECTION 106 0.0023
821 PSORIASIS 301 0.0023
822 RETCHING 49 0.0023
823 PAIN IN EXTREMITY 675 0.0023
824 WOUND 64 0.0023
825 UPPER RESPIRATORY TRACT INFECTION 105 0.0023
826 LETHARGY 130 0.0023
827 FREQUENT BOWEL MOVEMENTS 61 0.0023
828 PSORIATIC ARTHROPATHY 91 0.0022
829 RASH GENERALISED 58 0.0022
830 CEREBROVASCULAR ACCIDENT 379 0.0022
831 BLINDNESS 91 0.0022
832 BRADYCARDIA 118 0.0022
833 HYPOAESTHESIA 333 0.0022
834 VISION BLURRED 304 0.0022
835 CONDITION AGGRAVATED 673 0.0022
836 GASTROOESOPHAGEAL REFLUX DISEASE 177 0.0022
837 ADVERSE DRUG REACTION 197 0.0022
838 FUNGAL INFECTION 73 0.0022
839 HYPERSENSITIVITY 405 0.0022
840 CARPAL TUNNEL SYNDROME 30 0.0021
841 LACTIC ACIDOSIS 69 0.0021
842 CORONARY ARTERY DISEASE 64 0.0021
843 BLOOD URINE PRESENT 40 0.0021
844 VISUAL IMPAIRMENT 261 0.0021
845 SPEECH DISORDER 110 0.0021
846 HAEMORRHAGE 219 0.0021
847 URINARY INCONTINENCE 62 0.0021
848 LOSS OF CONSCIOUSNESS 266 0.0021
849 HEADACHE 1297 0.0021
850 HERNIA 40 0.0021
851 EAR PAIN 40 0.0021
852 ABDOMINAL PAIN LOWER 52 0.0021
853 SKIN FISSURES 40 0.0020
854 HYPOACUSIS 88 0.0020
855 PAIN 1255 0.0020
856 PRODUCT ADMINISTRATION ERROR 41 0.0020
857 GASTRIC CANCER 51 0.0020
858 CHEST DISCOMFORT 206 0.0020
859 SLEEP DISORDER 141 0.0020
860 MYOCARDIAL INFARCTION 342 0.0020
861 OSTEONECROSIS 64 0.0019
862 ARTHROPATHY 107 0.0019
863 PALLOR 52 0.0019
864 FLATULENCE 108 0.0019
865 COMA 90 0.0019
866 KIDNEY INFECTION 37 0.0019
867 DRUG INTOLERANCE 182 0.0019
868 LUNG NEOPLASM MALIGNANT 77 0.0019
869 VISUAL ACUITY REDUCED 62 0.0019
870 BONE DISORDER 34 0.0019
871 MUSCULOSKELETAL STIFFNESS 161 0.0018
872 ILLNESS 189 0.0018
873 CARDIAC DISORDER 171 0.0018
874 RED BLOOD CELL COUNT DECREASED 52 0.0018
875 SWELLING 170 0.0018
876 PARAESTHESIA 285 0.0018
877 CONTUSION 173 0.0018
878 JOINT STIFFNESS 47 0.0018
879 DYSSTASIA 52 0.0018
880 CHRONIC KIDNEY DISEASE 135 0.0018
881 TREATMENT FAILURE 147 0.0018
882 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 319 0.0018
883 PELVIC PAIN 32 0.0018
884 INFLUENZA 196 0.0018
885 TOXICITY TO VARIOUS AGENTS 295 0.0017
886 RESTLESSNESS 64 0.0017
887 GASTRIC DISORDER 60 0.0017
888 DIZZINESS 870 0.0017
889 CARDIOVASCULAR DISORDER 44 0.0017
890 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 83 0.0017
891 INSOMNIA 460 0.0017
892 ALOPECIA 338 0.0017
893 FLUSHING 174 0.0017
894 FLUID RETENTION 87 0.0017
895 HEAD INJURY 54 0.0017
896 DISEASE RECURRENCE 81 0.0017
897 RHINORRHOEA 110 0.0017
898 MEMORY IMPAIRMENT 232 0.0017
899 HAEMATOCRIT DECREASED 33 0.0017
900 VIRAL INFECTION 55 0.0017
901 TREMOR 267 0.0016
902 INTERVERTEBRAL DISC PROTRUSION 35 0.0016
903 JOINT SWELLING 193 0.0016
904 WEIGHT INCREASED 358 0.0016
905 PAIN OF SKIN 43 0.0016
906 DEPRESSED MOOD 83 0.0016
907 TINNITUS 72 0.0016
908 BALANCE DISORDER 135 0.0016
909 CARDIAC FAILURE CONGESTIVE 125 0.0016
910 MUSCLE SPASMS 284 0.0015
911 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 45 0.0015
912 NASOPHARYNGITIS 281 0.0015
913 PAIN IN JAW 43 0.0015
914 PROCEDURAL PAIN 42 0.0015
915 BLOOD PRESSURE ABNORMAL 30 0.0015
916 HYPERHIDROSIS 191 0.0015
917 HALLUCINATION 111 0.0015
918 LIMB INJURY 40 0.0015
919 DEPRESSION 334 0.0015
920 FULL BLOOD COUNT DECREASED 29 0.0014
921 NEOPLASM MALIGNANT 96 0.0014
922 PRURITUS GENERALISED 31 0.0014
923 MOOD ALTERED 39 0.0014
924 INTERNATIONAL NORMALISED RATIO INCREASED 40 0.0014
925 WHEEZING 83 0.0014
926 URTICARIA 230 0.0014
927 NO ADVERSE EVENT 248 0.0014
928 LACRIMATION INCREASED 41 0.0014
929 DRUG INEFFECTIVE 1788 0.0014
930 SWELLING FACE 88 0.0014
931 SWOLLEN TONGUE 42 0.0013
932 ABDOMINAL DISCOMFORT 225 0.0013
933 FEELING HOT 82 0.0013
934 LIP SWELLING 44 0.0013
935 ANGIOEDEMA 57 0.0013
936 TREATMENT NONCOMPLIANCE 70 0.0013
937 DISTURBANCE IN ATTENTION 69 0.0013
938 ELECTROCARDIOGRAM QT PROLONGED 46 0.0013
939 ANXIETY 362 0.0013
940 RESPIRATORY ARREST 35 0.0013
941 SURGERY 74 0.0013
942 THROAT TIGHTNESS 34 0.0013
943 PRODUCT DOSE OMISSION ISSUE 369 0.0013
944 EYE PAIN 70 0.0012
945 HOT FLUSH 93 0.0012
946 THERAPEUTIC RESPONSE DECREASED 74 0.0012
947 HEART RATE INCREASED 120 0.0012
948 THROAT IRRITATION 53 0.0012
949 SINUSITIS 120 0.0012
950 BURNING SENSATION 82 0.0012
951 HEART RATE DECREASED 40 0.0011
952 ACNE 86 0.0011
953 PLASMA CELL MYELOMA 44 0.0011
954 SYSTEMIC LUPUS ERYTHEMATOSUS 40 0.0011
955 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 38 0.0011
956 AMNESIA 73 0.0011
957 ILL-DEFINED DISORDER 68 0.0011
958 DRUG INTERACTION 176 0.0011
959 OSTEOARTHRITIS 47 0.0011
960 IRRITABILITY 65 0.0011
961 BLOOD GLUCOSE INCREASED 199 0.0011
962 OCULAR HYPERAEMIA 50 0.0011
963 SKIN IRRITATION 48 0.0010
964 PALPITATIONS 121 0.0010
965 RENAL INJURY 30 0.0010
966 MENTAL DISORDER 43 0.0010
967 OSTEOPOROSIS 40 0.0010
968 NASAL CONGESTION 55 0.0009
969 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 65 0.0009
970 THERAPY INTERRUPTED 65 0.0009
971 THERAPEUTIC RESPONSE UNEXPECTED 40 0.0009
972 MOBILITY DECREASED 62 0.0009
973 EYE SWELLING 32 0.0009
974 ASTHMA 97 0.0009
975 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 61 0.0009
976 NEPHROLITHIASIS 39 0.0008
977 AGITATION 61 0.0008
978 THERAPY CESSATION 41 0.0008
979 RENAL CANCER 38 0.0008
980 ROAD TRAFFIC ACCIDENT 33 0.0008
981 BLOOD GLUCOSE DECREASED 37 0.0008
982 FEELING ABNORMAL 173 0.0007
983 UNDERDOSE 49 0.0007
984 BLADDER CANCER 35 0.0006
985 MATERNAL EXPOSURE DURING PREGNANCY 50 0.0006
986 FOETAL EXPOSURE DURING PREGNANCY 38 0.0005
987 MIGRAINE 44 0.0005
988 COMPLETED SUICIDE 34 0.0004
989 BREAST CANCER 33 0.0004
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 60 0.0003
991 OVERDOSE 41 0.0002
992 INCORRECT DOSE ADMINISTERED 39 0.0002